Products for Research Use Only
RegisterLogin

TK-112690

CAT: 0804-HY-W008491-05Size: 100 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W008491-05Size:100 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TK-112690 is a UPP1 inhibitor. TK-112690 inhibits murine small intestinal uridine phosphorylase (UPase) with an IC50 of 12.5 μM and human small intestinal UPase with an IC50 of 20.0 μM in vitro. TK-112690 increases plasma uridine concentration in mice. TK-112690 can be used for the study of cancer and pulmonary fibrosis[1][2][3].
CAS Number
22423-26-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Concentration
10mM
Purity
99.91
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(C1=O)=CN(C2=N1)[C@@]3([H])[C@](O2)([H])[C@@](O)([H])[C@@](O3)([H])CO
Molecular Formula
C10H12N2O5
Molecular Weight
240.21
Precautions
H302, H315, H319, H335
References & Citations
[1]Strefeler A, et al. Nucleosides are overlooked fuels in central carbon metabolism. Trends Endocrinol Metab. 2024 Apr;35 (4) :290-299. |[2]William A. Garland, et al. Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same. US 9,382,287 B2. United States Patent and Trademark Office (USPTO) . Jul. 5, 2016. |[3]William A. Garland, et al. Uridine Phosphorylase Inhibitors to Treat or Prevent Pulmonary Disease. US 2025/0222000 A1. United States Patent and Trademark Office (USPTO) . Jul. 10, 2025.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported

Chemical Information

2,2'-Anhydro-1-beta-arabinofuranosylthymine

Uridine Phosphorylase Inhibitor TK-112690 is a 2,2'-anhydropyrimidine derivative and human uridine phosphorylase (UPase) inhibitor that can be used to suppress mucositis induced by certain chemotherapeutics. Upon administration of UPase inhibitor TK-112690 prior to the administration of certain chemotherapeutic agents, such as methotrexate (MTX), this agent targets, binds to and blocks the activity of UPase, thereby preventing the metabolic breakdown of uridine into uracil. This increases the uridine levels in plasma and may prevent mucositis. By rescuing normal tissue, TK-112690 may enhance the therapeutic index of the chemotherapeutic agent. UPase plays a key role in in pyrimidine metabolism, and catabolizes uridine into uracil and ribose-1-phosphate.

CAS Number22423-26-3
PubChem CID168045
IUPAC Name(2R,4R,5R,6S)-5-hydroxy-4-(hydroxymethyl)-11-methyl-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-10-one
Molecular FormulaC10H12N2O5
Molecular Weight240.21
XLogP-2.1
Topological Polar Surface Area91.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Heavy Atom Count17
Formal Charge0
Complexity432
SMILES
CC1=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)OC2=NC1=O
InChI
InChI=1S/C10H12N2O5/c1-4-2-12-9-7(6(14)5(3-13)16-9)17-10(12)11-8(4)15/h2,5-7,9,13-14H,3H2,1H3/t5-,6-,7+,9-/m1/s1
InChIKey
WLLOAUCNUMYOQI-JAGXHNFQSA-N
Chemical Structure
2D Structure
2D structure of 2,2'-Anhydro-1-beta-arabinofuranosylthymine
CAS: 22423-26-3
CID: 168045
Formula: C10H12N2O5
MW: 240.21
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight240.21
XLogP3-2.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass240.07462149
Monoisotopic Mass240.07462149
Topological Polar Surface Area91.6 Ų
Heavy Atom Count17
Formal Charge0
Complexity432
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-169436Lon-TK
HY-173571TK-685
HY-P1079ω-Agatoxin TK
HY-158762TK-642
HY-173573TK-684
HY-151483-01TK-129
HY-169435-01TK-OH
HY-158018EGFR-TK-IN-2
HY-161927-01EGFR-TK-IN-4
HY-157526EGFR-TK-IN-1

Alternative Products

CatalogName
ARC0953TK
257183ω-Agatoxin TK
MBS8512170-01TK Antibody
MBS5803436TK-129
T210621-01TK-685
579086-01TK (HRP)
D2760-100μgPRL-TK
P61538PHSV-TK

Popular Products